| Name | Title | Contact Details |
|---|
Bridgeway has been dedicated to in-house legal departments for 20 years. Our staff of dedicated professionals has the education, knowledge, skills, experience and expertise to provide the technology and services you need to enable the best litigation
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
The best websites for photographers. Get a site, built-in photo selling, unlimited storage, client proofing and more. Simple. Fast. 14-day free trial.
Looking for Field Sales Management Software? Skynamo is the safe choice for storing your customer data. We are ISO 27001 certified and GDPR compliant.
Expert app developers and designers from ArcTouch, a top San Francisco based app development company that creates lovable apps for the connected world.